Premium
Pharmacokinetics of enrofloxacin and its efficacy in comparison with doxycycline in the treatment of Chlamydophila felis infection in cats with conjunctivitis
Author(s) -
Gerhardt N.,
Schulz B. S.,
Werckenthin C.,
Hartmann K.
Publication year - 2006
Publication title -
veterinary record
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.261
H-Index - 99
eISSN - 2042-7670
pISSN - 0042-4900
DOI - 10.1136/vr.159.18.591
Subject(s) - enrofloxacin , doxycycline , cats , medicine , pharmacokinetics , chlamydophila , virology , antibiotics , biology , veterinary medicine , microbiology and biotechnology , ciprofloxacin , immunology , chlamydia
The concentrations of enrofloxacin were measured in the tears, saliva and serum of 14 cats with signs of upper respiratory tract infection and eight with no signs, after daily doses of 5 mg/kg. Enrofloxacin concentrations above the minimum inhibitory concentration of Chlamydophila felis were found in the saliva and tears of the cats with and without signs of upper respiratory tract infection. In a prospective randomised clinical trial, the efficacy of enrofloxacin against C felis infection in cats with conjunctivitis was compared with the efficacy of doxycycline. Twenty‐five cats were randomly assigned to treatment with either enrofloxacin or doxycycline for 14 days; 15 of the cats tested positive for C felis by an immunofluorescent antibody test on conjunctival swabs. The two treatment groups showed equal improvements in the clinical signs of conjunctivitis and C felis infection status; in each group three cats were still C felis antigen‐positive after the 14‐day course of treatment, indicating a persistent infection. No side effects were observed in the cats treated with enrofloxacin.